Anixa Biosciences ANIX
NASDAQ ANIX
$2.77 -0.16 (-5.46%)
At close: Oct 1, 2026 · 4:00 PM EDT

Anixa Biosciences (ANIX) Debt Ratio (2014 - 2017)

Updated

Anixa Biosciences' (ANIX) Debt Ratio was 0.24 for fiscal Q3 2017 (quarter ended Jul 31, 2017), down 42.6% from the prior quarter.

Analysis

Anixa Biosciences (ANIX) Debt Ratio (2014 - 2017) Analysis & Trends

Dating back to fiscal Q1 2014, Anixa Biosciences' Debt Ratio record includes 4 quarters.

  • The fiscal Q3 2017 figure ranks as the lowest quarterly Debt Ratio since fiscal Q1 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.24
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.52
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.42
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.31
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.00
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.60
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.53
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Anixa Biosciences 101.33 Mn 100.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2017 0.24
Apr 30, 2017 0.41
Jan 31, 2017 1.42
Jan 31, 2014 0.06
API Access

Anixa Biosciences Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ANIX&period=max&api_key=YOUR_API_KEY